» Articles » PMID: 24083506

Transmission Potential of Influenza A/H7N9, February to May 2013, China

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2013 Oct 3
PMID 24083506
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: On 31 March 2013, the first human infections with the novel influenza A/H7N9 virus were reported in Eastern China. The outbreak expanded rapidly in geographic scope and size, with a total of 132 laboratory-confirmed cases reported by 3 June 2013, in 10 Chinese provinces and Taiwan. The incidence of A/H7N9 cases has stalled in recent weeks, presumably as a consequence of live bird market closures in the most heavily affected areas. Here we compare the transmission potential of influenza A/H7N9 with that of other emerging pathogens and evaluate the impact of intervention measures in an effort to guide pandemic preparedness.

Methods: We used a Bayesian approach combined with a SEIR (Susceptible-Exposed-Infectious-Removed) transmission model fitted to daily case data to assess the reproduction number (R) of A/H7N9 by province and to evaluate the impact of live bird market closures in April and May 2013. Simulation studies helped quantify the performance of our approach in the context of an emerging pathogen, where human-to-human transmission is limited and most cases arise from spillover events. We also used alternative approaches to estimate R based on individual-level information on prior exposure and compared the transmission potential of influenza A/H7N9 with that of other recent zoonoses.

Results: Estimates of R for the A/H7N9 outbreak were below the epidemic threshold required for sustained human-to-human transmission and remained near 0.1 throughout the study period, with broad 95% credible intervals by the Bayesian method (0.01 to 0.49). The Bayesian estimation approach was dominated by the prior distribution, however, due to relatively little information contained in the case data. We observe a statistically significant deceleration in growth rate after 6 April 2013, which is consistent with a reduction in A/H7N9 transmission associated with the preemptive closure of live bird markets. Although confidence intervals are broad, the estimated transmission potential of A/H7N9 appears lower than that of recent zoonotic threats, including avian influenza A/H5N1, swine influenza H3N2sw and Nipah virus.

Conclusion: Although uncertainty remains high in R estimates for H7N9 due to limited epidemiological information, all available evidence points to a low transmission potential. Continued monitoring of the transmission potential of A/H7N9 is critical in the coming months as intervention measures may be relaxed and seasonal factors could promote disease transmission in colder months.

Citing Articles

Policies to prevent zoonotic spillover: a systematic scoping review of evaluative evidence.

Clifford Astbury C, Lee K, Mcleod R, Aguiar R, Atique A, Balolong M Global Health. 2023; 19(1):82.

PMID: 37940941 PMC: 10634115. DOI: 10.1186/s12992-023-00986-x.


Bayesian phylodynamics reveals the transmission dynamics of avian influenza A(H7N9) virus at the human-live bird market interface in China.

Guinat C, Tang H, Yang Q, Valenzuela Agui C, Vaughan T, Scire J Proc Natl Acad Sci U S A. 2023; 120(17):e2215610120.

PMID: 37068240 PMC: 10151560. DOI: 10.1073/pnas.2215610120.


Regional Distribution of Non-human H7N9 Avian Influenza Virus Detections in China and Construction of a Predictive Model.

Huang Z, Li H, Huang B J Vet Res. 2021; 65(3):253-264.

PMID: 34917836 PMC: 8643092. DOI: 10.2478/jvetres-2021-0034.


A simple mathematical tool to forecast COVID-19 cumulative case numbers.

Balak N, Inan D, Ganau M, Zoia C, Sonmez S, Kurt B Clin Epidemiol Glob Health. 2021; 12:100853.

PMID: 34395949 PMC: 8352661. DOI: 10.1016/j.cegh.2021.100853.


Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine.

Viboud C, Gostic K, Nelson M, Price G, Perofsky A, Sun K PLoS Pathog. 2020; 16(9):e1008583.

PMID: 32970783 PMC: 7514029. DOI: 10.1371/journal.ppat.1008583.


References
1.
Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J . Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013; 381(9881):1916-25. PMC: 7134567. DOI: 10.1016/S0140-6736(13)60903-4. View

2.
Riley S, Fraser C, Donnelly C, Ghani A, Abu-Raddad L, Hedley A . Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003; 300(5627):1961-6. DOI: 10.1126/science.1086478. View

3.
Pitzer V, Olsen S, Bergstrom C, Dowell S, Lipsitch M . Little evidence for genetic susceptibility to influenza A (H5N1) from family clustering data. Emerg Infect Dis. 2008; 13(7):1074-6. PMC: 2878232. DOI: 10.3201/eid1307.061538. View

4.
White L, Wallinga J, Finelli L, Reed C, Riley S, Lipsitch M . Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respir Viruses. 2009; 3(6):267-76. PMC: 2782458. DOI: 10.1111/j.1750-2659.2009.00106.x. View

5.
Nishiura H, Castillo-Chavez C, Safan M, Chowell G . Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Euro Surveill. 2009; 14(22). DOI: 10.2807/ese.14.22.19227-en. View